Hui Peng

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Induced Apoptosis

Natural Killer Cells

Regulatory T Cells

Top Venues

Science (New York, N.Y.)

The Journal of experimental medicine

Nature communications

Cancer immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Yongjing Shi, Xiaodong Zheng, Hui Peng, Chenqi Xu, Rui Sun, Zhigang Tian, Haoyu Sun, Xianwei Wang
The E3 ubiquitin ligase FBXO38 maintains the antitumor function of natural killer cells by sustaining IL-15R signaling. Cancer immunology research (2024)
Yawen Chen, Xianwei Wang, Xiaolei Hao, Bin Li, Wanyin Tao, Shu Zhu, Kun Qu, Haiming Wei, Rui Sun, Hui Peng, Zhigang Tian
Ly49E separates liver ILC1s into embryo-derived and postnatal subsets with different functions. The Journal of experimental medicine 219 (5) (2022)
Lu Bai, Margaux Vienne, Ling Tang, Yann M Kerdiles, Marion Etiennot, Bertrand Escalière, Justine Galluso, Haiming Wei, Rui Sun, Éric Vivier, Hui Peng, Zhigang Tian
Liver type 1 innate lymphoid cells develop locally via an interferon-γ-dependent loop. Science (New York, N.Y.) 371 (6536) (2021)
Hao Song, Jiaxi Song, Ming Cheng, Meijuan Zheng, Tian Wang, Sha Tian, Richard A Flavell, Shu Zhu, Hua-Bing Li, Chen Ding, Haiming Wei, Rui Sun, Hui Peng, Zhigang Tian
METTL3-mediated m6A RNA methylation promotes the anti-tumour immunity of natural killer cells. Nature communications 12 (1) (2021)